Ingevity sees FY23 revenue $1.9B-$2.1B, consensus $1.83B

Sees FY23 adjusted EBITDA $495M-$515M. "2023 kicked off to a slower start but we expect to see order patterns normalize and to benefit from a recovery in key end-markets such as auto and adhesives. This expected recovery combined with the continued strength in markets such as oilfield, footwear and apparel, and pavement, including a full year of Ozark Materials, gives us confidence in our growth outlook for 2023," said Fortson.